Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Mometasone Furoate 0.6 mg Capsules (For Nasal Irrigation/Nebulizer)

FDA-approved generic
Dose form
Nasal Irrigation/Nebulizer Capsules
Active ingredients
Mometasone Furoate
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Mometasone Furoate
Nasal Irrigation/Nebulizer Capsules
6427079ea643249f05518e9c
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded capsule for nasal irrigation or nebulizer use containing mometasone furoate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing mometasone are listed in spray, ointment, cream, aerosol, solution and inhalant forms. No finished mometasone product of any kind is listed in capsule form.

Storage category and dating

This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Prescribers order these capsules to be mixed into a saline sinus rinse for patients with chronic sinusitis or nasal polyps, often after sinus surgery. Manufactured mometasone is FDA-approved as a nasal spray for these conditions; adding it to a sinus rinse is off-label.

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Mometasone furoate is a medium-potency topical corticosteroid that compounding pharmacies prepare as creams, ointments, lotions and solutions by prescription.

About this ingredient

Mometasone furoate is a synthetic corticosteroid. Applied to the skin, it enters cells and switches on anti-inflammatory proteins, including lipocortins, which calm the redness, swelling and itch of inflamed skin and narrow small blood vessels. Among topical steroids it sits in the medium-potency range, and only about 0.4 percent of an applied dose reaches the bloodstream through intact skin. Manufactured mometasone furoate cream, ointment and lotion (originally Elocon, now generics) are FDA-approved for relief of the inflammatory and itchy manifestations of corticosteroid-responsive dermatoses in patients two years and older. A prescriber might order compounded mometasone for a vehicle not manufactured, a base free of a preservative or lanolin a patient reacts to, or a combination with another topical ingredient in a single preparation. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

Mometasone is for the skin only; keep it out of the eyes and mouth, and do not use it if you have reacted to it before. Avoid the face, groin and skin folds unless directed, and do not cover treated skin with bandages, plastic or diapers, which drive more steroid into the body. Enough can be absorbed, especially in children or over large areas, to suppress the adrenal glands, raise blood sugar or cause Cushing's syndrome. Topical steroids have been linked to cataracts and glaucoma; report any vision change. Common local effects are burning, itching, thinning skin, stretch marks and color change. Tell your prescriber about every steroid you use. Use in pregnancy only if clearly needed; LactMed considers short courses unlikely to harm a breastfed infant but says to keep the infant's skin away from treated areas. If side effects bother you, talk to your prescriber or pharmacist.

Mometasone furoate is a 17-heterocyclic corticosteroid with anti-inflammatory, antipruritic and vasoconstrictive activity; the label attributes the effect to induction of lipocortins that inhibit phospholipase A2. Percutaneous absorption is about 0.4 percent of the applied dose over eight hours on intact unoccluded skin and higher on inflamed skin or under occlusion. Potency is medium (groups IV to V in the AAFP classification). Labeled indication for mometasone furoate cream, ointment and lotion (generics; Elocon brand discontinued): inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, age two and older; the label limits pediatric use to three weeks and advises against diaper-area use. In a pediatric study of extensive application, adrenal suppression occurred in about 16 percent of subjects. No drug interaction studies have been conducted. Prescribers select the vehicle for the lesion type per AAFP guidance (ointments for dry hyperkeratotic plaques, creams for weeping or intertriginous skin, lotions for hairy areas); strength and duration are per prescriber. Monitoring: local atrophy, striae and telangiectasia, allergic contact dermatitis presenting as failure to heal, and HPA axis evaluation (cortisol or ACTH stimulation) when large areas, occlusion or prolonged use are involved. Tachyphylaxis can develop with continuous use. Not a controlled substance.

Sources

Using and storing

How it is used

Wash your hands. Open one capsule and empty the powder into the volume of saline or water on your label, using only distilled, sterile, or boiled and cooled water if you are mixing it yourself. Stir or shake until dissolved. For a sinus rinse, lean over a sink and rinse each nostril with the device. For a nebulizer, pour the solution into the medicine cup and breathe normally through the mouthpiece or mask until the mist stops. Wash and air dry the rinse device or nebulizer cup after each use. Discard any mixed solution you do not use.

Storing it

Keep the unopened capsules tightly closed in a dry place at room temperature and out of reach of children. The beyond-use date on your label depends on how the capsules were prepared and what they are for; the pharmacist sets it. Mix only one dose at a time and discard capsules after the beyond-use date on your label.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Mometasone Furoate 0.6 mg Capsules (For Nasal Irrigation/Nebulizer)
Nasal Irrigation/Nebulizer Capsules
1000 mL
controlled

Empty contents of 1 capsule and mix with saline solution and irrigate/nebulize

Twice daily